ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2026
Linear Inverse Association Between Triglyceride Glucose-Body Mass Index and Osteoporosis in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study.
Article in Diabetes, metabolic syndrome and obesity : targets and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: This study was to evaluate the association between triglyceride glucose-body mass index (TyG-BMI) and osteoporosis in patients with type 2 diabetes mellitus (T2DM). Methods: In this cross-sectional study, 892 patients with T2DM hospitalized at Zhengrzhou Central Hospital between April 2024 and March 2025 were included. Participants were grouped into TyG-BMI tertiles (T1 ≤ 209.31, T2 209.31-243.39, T3 > 243.39). Logistic regression analysis, subgroup and sensitivity analyses, receiver operating characteristic (ROC) curve analysis, and restricted cubic spline (RCS) modeling were performed to evaluate the relationship between TyG-BMI and osteoporosis. Results: After adjusting for potential confounders, each one-unit increase in TyG-BMI was associated with a 1.5% lower odds of osteoporosis (OR = 0.985, 95% CI: 0.978-0.992). Compared with T1, the odds of osteoporosis were significantly reduced in T2 and T3 (T2: OR = 0.565, 95% CI: 0.352-0.908; T3: OR = 0.322, 95% CI: 0.167-0.620). Subgroup analyses confirmed that the inverse association remained stable across most demographic and clinical strata. Sensitivity analyses further supported this trend: participants in the highest TyG-BMI quartile had a 74.8% lower risk of osteoporosis compared with those in the lowest quartile. Individuals with TyG-BMI above the median also showed a markedly reduced osteoporosis risk. ROC analysis showed TyG-BMI had a higher predictive value (AUC = 0.657) for osteoporosis than TyG index (AUC = 0.554) or BMI (AUC = 0.647) alone. RCS analysis indicated a significant linear negative relationship without evidence of nonlinearity (P for nonlinearity = 0.720). Conclusion: Higher TyG-BMI levels are inversely associated with the risk of osteoporosis in patients with T2DM.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.